drugset
drugset / Trial / NCT04548518

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly

NCT04548518 ↗

Phase 3 Unknown 816 enrolled Mahidol University The Government Pharmaceutical Organization · collab
RandomizedParallel-groupDouble-blindPrevention

Summary

The study is aim to evaluate the Immunogenicity with two groups of participants who will received a seasonal trivalent split, inactivated influenza vaccine (A/H1N1; A/H3N2 and B) or an active comparator (licensed influenza vaccine).

Timeline

Start
2020-08-03
Primary completion
2023-06-30
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator GPO Tri Fluvac vaccine Vaccine 0.5 ml Intramuscular
Comparator Licensed influenza vaccine Vaccine 0.5 ml Intramuscular

Indications

influenza